Research publications | Alfred Health

Out of sight, out of mind: long-term outcomes for people discharged home, to inpatient rehabilitation and to residential aged care after stroke

Lynch EA, Labberton AS, Kim J, Kilkenny MF, Andrew NE, Lannin NA, Grimley R, Faux SG, Cadilhac DA; Stroke123 Investigators and AuSCR Consortium

(2022), Disabil Rehabil, 44(12), 2608-14

DOI: 10.1080/09638288.2020.1852616

Implementing a choice of pulmonary rehabilitation models in chronic obstructive pulmonary disease (HomeBase2 trial): protocol for a cluster randomised controlled trial

Holland AE, Jones AW, Mahal A, Lannin NA, Cox N, Hepworth G, O'Halloran P, McDonald CF

(2022), BMJ Open, 12(4), e057311

DOI: 10.1136/bmjopen-2021-057311

Stroke rehabilitation research translation in Australia: a survey of clinical trialists

Jolliffe L, Hoffmann T, Laver K, McCluskey A, Lannin NA

(2022), Disabil Rehabil, 44(10), 2131-7

DOI: 10.1080/09638288.2020.1807619

When immunosuppression and COVID-19 intersect: An exploratory qualitative study of young lung transplant recipient perceptions of daily life during a pandemic

Hatzikiriakidis K, West S, Ayton D, Morris H, Martin RS, Paraskeva M

(2022), Pediatr Transplant, 26(5), e14281

DOI: 10.1111/petr.14281

Discharge planning from hospital (review)

Gonçalves-Bradley, D C, Lannin, N A, Clemson, L, Cameron, ID, & Shepperd, S

(2022), COCHRANE DB SYST REV, (2), CD000313

DOI: 10.1002/14651858.CD000313.pub6

AUS-TBI: The Australian Health Informatics Approach to Predict Outcomes and Monitor Intervention Efficacy after Moderate-to-Severe Traumatic Brain Injury

Fitzgerald M, Ponsford J, Lannin NA, O'Brien TJ, Cameron P, Cooper DJ, Rushworth N, Gabbe B

(2022), Neurotrauma Reports, 3(1), 217-23

DOI: 10.1089/neur.2022.0002

Living clinical guidelines for stroke: updates, challenges and opportunities

English C, Hill K, Cadilhac DA, Hackett ML, Lannin NA, Middleton S, Ranta A, Stocks NP, Davey J, Faux SG, Godecke E, Campbell BC

(2022), MED J AUSTRALIA, 216(10), 510-4

DOI: 10.5694/mja2.51520

Early-phase dose articulation trials are underutilized for post-stroke motor recovery: A systematic scoping review

Dalton EJ, Churilov L, Lannin NA, Corbett D, Campbell BCV, Hayward KS

(2022), Ann Phys Rehabil Med, 65(1), 101487

DOI: 10.1016/j.rehab.2021.101487

Understanding of medications and associations with adherence, unmet needs, and perceived control of risk factors at two years post-stroke

Dalli LL, Andrew NE, Kim J, Cadilhac DA, Sanfilippo FM, Thrift AG, Nelson MR, Lannin NA, Olaiya MT, Ryan OF, Booth B, Gall S, Kilkenny MF; PRECISE investigators

(2022), RES SOC ADMIN PHARM, 18(9), 3542-9

DOI: 10.1016/j.sapharm.2022.01.007

A mixed-methods feasibility study of a new digital health support package for people after stroke: the Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke (ReCAPS) intervention

Cameron J, Lannin NA, Harris D, Andrew NE, Kilkenny MF, Purvis T, Thrift AG, Thayabaranathan T, Ellery F, Sookram G, Hackett M, Kneebone I, Drummond A, Cadilhac DA; Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke (ReCAPS) Investigators

(2022), Pilot and Feasibility Studies, 8(1), 241

DOI: 10.1186/s40814-022-01197-8

Effect of the Coronavirus Disease 2019 Pandemic on the Quality of Stroke Care in Stroke Units and Alternative Wards: A National Comparative Analysis

Cadilhac DA, Kim J, Cloud G, Anderson CS, Tod EK, Breen SJ, Faux S, Kleinig T, Castley H, Lindley RI, Middleton S, Yan B, Hill K, Jones B, Shah D, Jaques K, Clissold B, Campbell B, Lannin NA; AuSCR COVID-19 Reporting Consortium Group

(2022), J Stroke, 24(1), 79-87

DOI: 10.5853/jos.2021.02530

A Stepped-Wedge Cluster-Randomized Trial to Improve Adherence to Evidence-Based Practices for Acute Stroke Management

Cadilhac DA, Marion V, Andrew NE, Breen SJ, Grabsch B, Purvis T, Morrison JL, Lannin NA, Grimley RS, Middleton S, Kilkenny MF

(2022), Joint Commission journal on quality and patient safety, 48(12), 653-64

DOI: 10.1016/j.jcjq.2022.09.003

Development and field testing of a standardised goal setting package for person-centred discharge care planning in stroke

Barnden, R, Cadilhac, D, Lannin, N, Kneebone, I, Hersh, D, Godecke, E, Stolwy, R, Purvis, T, Nicks, R, Farquhar, M, Gleeson, S, Gore, C, Herrmann, K, & Andrew, N

(2022), PEC Innovation, 1(2022), 100008

DOI: 10.1016/j.pecinn.2021.100008

Denial of Cerebrovascular Events in a National Clinical Quality Registry for Stroke: A Retrospective Cohort Study

Barclay KM, Kilkenny MF, Breen SJ, Ryan OF, Bagot KL, Lannin NA, Thijs V, Cadilhac DA; AuSCR Consortium

(2022), J STROKE CEREBROVASC, 31(2), 106210

DOI: 10.1016/j.jstrokecerebrovasdis.2021.106210

Developing tailored theoretically informed goal-setting interventions for rehabilitation services: a co-design approach

Baker A, Cornwell P, Gustafsson L, Stewart C, Lannin NA

(2022), BMC Health Serv Res, 22(1), 811

DOI: 10.1186/s12913-022-08047-6

An exploration of goal-setting practices in Queensland rehabilitation services

Baker A, Cornwell P, Gustafsson L, Lannin NA

(2022), Disabil Rehabil, 44(16), 4368-78

DOI: 10.1080/09638288.2021.1906957

Implementation of a leisure reintegration programme for people with acquired brain injury in a community rehabilitation programme: a feasibility study

Alves-Stein S, George S, Lannin NA, Jolliffe L

(2022), BRAIN IMPAIR, 1-3,

DOI: 10.1017/BrImp.2022.8

Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus

Maharaj AD, Lubel J, Lam E, Clark PJ, Duncan O, George J, Jeffrey GP, Lipton L, Liu H, McCaughan G, Neo EL, Philip J, Strasser SI, Stuart K, Thompson A, Tibballs J, Tu T, Wallace MC, Wigg A, Wood M, Zekry A, Greenhill E, Ioannou LJ, Ahlenstiel G, Bowers K, Clarke SJ, Dev A, Fink M, Goodwin M, Karapetis CS, Levy MT, Muller K, O'Beirne J, Pryor D, Seow J, Shackel N, Tallis C, Butler N, Olynyk JK, Reed-Cox K, Zalcberg JR, Roberts SK

(2022), Hepatol Commun, 6(11), 3260-70

DOI: 10.1002/hep4.2089

Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors

Papadatos-Pastos D, Yuan W, Pal A, Crespo M, Ferreira A, Gurel B, Prout T, Ameratunga M, Chénard-Poirier M, Curcean A, Bertan C, Baker C, Miranda S, Masrour N, Chen W, Pereira R, Figueiredo I, Morilla R, Jenkins B, Zachariou A, Riisnaes R, Parmar M, Turner A, Carreira S, Yap C, Brown R, Tunariu N, Banerji U, Lopez J, de Bono J, Minchom A

(2022), J Immunother Cancer, 10(6), e004495

DOI: 10.1136/jitc-2022-004495

A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancers

Gan HK, Parakh S, Lee FT, Tebbutt NC, Ameratunga M, Lee ST, O'Keefe GJ, Gong SJ, Vanrenen C, Caine J, Giovannetti M, Murone C, Scott FE, Guo N, Burvenich IJG, Paine C, Macri MJ, Kotsuma M, Senaldi G, Venhaus R, Scott AM

(2022), Invest New Drug, 40(4), 747-55

DOI: 10.1007/s10637-022-01237-3